Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

LM Kenny, RC Coombes, I Oulie… - Journal of nuclear …, 2008 - Soc Nuclear Med
The integrin α v β 3 receptor is upregulated on tumor cells and endothelium and plays
important roles in angiogenesis and metastasis. Arg-Gly-Asp (RGD) peptide ligands have high …

Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging …

LM Kenny, DM Vigushin, A Al-Nahhas, S Osman… - Cancer research, 2005 - AACR
There is an unmet need to develop imaging methods for the early and objective assessment
of breast tumors to therapy. 3′-Deoxy-3′-[ 18 F]fluorothymidine ([ 18 F]FLT)–positron …

Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase …

…, G Tomasi, A Al-Nahhas, P Mapelli, LM Kenny… - Clinical Cancer …, 2011 - AACR
Purpose: To evaluate the accuracy and biological basis for [ 11 C]choline-PET-CT in the
nodal staging of high risk localized prostate cancer patients. Experimental Design: Twenty-eight …

[HTML][HTML] FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression

…, F Mauri, RM Szydlo, S Yao, EWF Lam, LM Kenny - Scientific reports, 2019 - nature.com
Resistance to 5-Fluoruracil (5-FU) has been linked to elevated expression of the main target,
thymidylate synthase (TYMS), which catalyses the de novo pathway for production of …

Reproducibility of 18F-FDG and 3′-deoxy-3′-18F-fluorothymidine PET tumor volume measurements

…, EO Aboagye, LM Kenny… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The objective of this study was to establish the repeatability and reproducibility limits of
several volume-related PET image–derived indices—namely tumor volume (TV), mean …

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment

…, CY Koo, AR Gomes, PH Pinto, V Varghese, LM Kenny… - Oncogene, 2013 - nature.com
FOXM1 is implicated in genotoxic drug resistance but its role and mechanism of action
remain unclear. Here, we establish that γH2AX foci, indicative of DNA double-strand breaks (…

18F-ICMT-11, a caspase-3–specific PET tracer for apoptosis: biodistribution and radiation dosimetry

A Challapalli, LM Kenny, WA Hallett… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Effective anticancer therapy induces tumor cell death through apoptosis. Noninvasive monitoring
of apoptosis during therapy may provide predictive outcome information and help tailor …

[HTML][HTML] Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer

A Saleem, GE Searle, LM Kenny, M Huiban… - EJNMMI research, 2015 - Springer
Background Brain metastases are common in human epidermal growth factor receptor (Her)-2-positive
breast cancer. Drug access to brain metastases and normal brain is key to …

[18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel

KB Contractor, LM Kenny, J Stebbing, L Rosso… - Clinical Cancer …, 2011 - AACR
Purpose: To establish biomarkers indicating clinical response to taxanes, we determined
whether early changes in [ 18 F]-3′deoxy-3′-fluorothymidine positron emission tomography (…

The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers

…, MP Miller, TJ Spinks, LM Kenny… - Journal of Nuclear …, 2008 - Soc Nuclear Med
We report the safety, biodistribution, and internal radiation dosimetry of a new PET tracer,
18 F-AH111585, a peptide with a high affinity for the α v β 3 integrin receptor involved in …